SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-005894
Filing Date
2022-03-03
Accepted
2022-03-03 08:35:29
Documents
14
Period of Report
2022-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43324
2 ex99-1.htm EX-99.1 14258
3 logo_001.jpg GRAPHIC 6090
  Complete submission text file 0001493152-22-005894.txt   246751

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20220301.xsd EX-101.SCH 3033
5 XBRL LABEL FILE aim-20220301_lab.xml EX-101.LAB 35156
6 XBRL PRESENTATION FILE aim-20220301_pre.xml EX-101.PRE 23030
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3657
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 22706827
SIC: 2836 Biological Products, (No Diagnostic Substances)